APM - Aptorum Group Limited

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

Aptorum Group Limited

Guangdong Investment Tower
17th Floor 148 Connaught Road
Hong Kong
852 2117 6611

Full Time Employees39

Key Executives

NameTitlePayExercisedYear Born
Mr. Chung Yuen HuenFounder, Chairman & CEO300kN/A1980
Mr. Darren LuiPres & Exec. Director250kN/A1981
Ms. Sabrina KhanChief Financial Officer286.27kN/A1981
Mr. Clark ChengChief Medical Officer & Exec. Director262.95kN/A1980
Dr. Siu-yan NgChief Operating OfficerN/AN/A1981
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Aptorum Group Limited, a pharmaceutical company, develops and commercializes a range of therapeutic and diagnostic technologies to treat unmet medical needs. It focuses on developing various drug molecules and certain technologies for the treatment and diagnosis of human disease conditions in neurology, infectious diseases, gastroenterology, oncology, and other disease areas. The company also focuses on the development of surgical robotics and medical devices; and operating outpatient clinic. Aptorum Group Limited was incorporated in 2010 and is headquartered in Central, Hong Kong.

Corporate Governance

Aptorum Group Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.